Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of timolol + dorzolamide therapy on ocular autoregulation in glaucoma
2012-004946-13Phase 4Terminated
- Sponsor
- UZ Leuven
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dorzolamide in open-angle glaucoma (OAG) (2 arms), sponsored by UZ Leuven. Primary endpoints: Change in resistivity index of retrobulbar arteries and Change in pulsatility index of retrobulbar arteries. Started Aug 2013; status: terminated.
02
Drugs
dorzolamide
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2012-004946-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004946-13.